Clinical Trial Update: Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating oral Prurisol for active mild-to-moderate plaque psoriasis reports efficacy and safety data, with the study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Prurisol

Snippet

Sponsor: Cellceutix Corporation | Conditions: Plaque Psoriasis | Phase 2 | Status: COMPLETED